Sort by
Refine Your Search
-
Category
-
Employer
-
Field
-
28 Jun 2026 Job Information Organisation/Company CNRS Department Institut de Physique des deux Infinis de Lyon Research Field Chemistry Chemistry » Computational chemistry Researcher Profile First
-
1 Aug 2026 Job Information Organisation/Company CNRS Department Institut de recherche sur les céramiques Research Field Mathematics History » History of science Researcher Profile First Stage
-
23 Jun 2026 Job Information Organisation/Company CNRS Department Institut de génomique fonctionnelle Research Field Neurosciences Biological sciences Researcher Profile Recognised Researcher (R2
-
19 Jun 2026 Job Information Organisation/Company CNRS Department Institut des sciences analytiques et de physico-chimie pour l'environnement et les matériaux Research Field Chemistry Biological
-
18 Jun 2026 Job Information Organisation/Company Nantes Université Department CEISAM UMR-CNRS 6230 Research Field Chemistry » Organic chemistry Researcher Profile First Stage Researcher (R1
-
PhD in organic chemistry (M/F) – Development of self-optimizing flow reactors for chemical reactions
to revolutionize organic synthesis through flow chemistry and automation tools. Where to apply Website https://amethis.doctorat.org/amethis-client/prd/consulter/offre/3680 Requirements Research FieldChemistry
-
with the Institute of Pharmacology and Structural Biology (IPBS), which will provide expertise in macrophage biology, cell biology and the mechanobiology of phagocytosis. Where to apply Website https
-
Work Location(s) Number of offers available1Company/InstituteInstitut des sciences analytiques et de physico-chimie pour l'environnement et les matériauxCountryFranceCityPAU Contact City PAU Website http
-
23 Jun 2026 Job Information Organisation/Company CNRS Department Chimie et Biologie des Membranes et des Nanoobjets Research Field Biological sciences Researcher Profile First Stage Researcher (R1
-
French National Institute for Health Research (INSERM) | Paris 15, le de France | France | about 2 months ago
to vaccination. The approaches developed will combine molecular biology, omics analyses, and bioinformatics, using both experimental models and clinical samples. This chair fully aligns with INSERM’s strategic